Loading...
Interleukin-35 limits anti-tumor immunity
Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune sequelae limits its utility in the clinic and highlights the need for limiting Treg cell activity within the tumor microenvironment. Interleu...
Na minha lista:
| Udgivet i: | Immunity |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758699/ https://ncbi.nlm.nih.gov/pubmed/26872697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2016.01.013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|